UrgoClean® presents better desloughing properties than Aquacel®, up to 50% higher, clinically proven in a large Randomized Controlled Trial*

News & Event

UrgoClean® presents better desloughing properties than Aquacel®, up to 50% higher, clinically proven in a large Randomized Controlled Trial*

The EARTH study is a RCT that compared UrgoClean® and Aquacel®, in the local management of venous or mixed leg ulcers predominantly of venous origin, at the debridement stage of the healing process. The results confirmed that UrgoClean® is similar in terms of efficacy (healing properties) to the control dressing Aquacel®, after 6 weeks of treatment (surface area reduced respectively by 34.1% and 34.4%).

 

However, the autolytic debridement capacity of UrgoClean® is documented to be superior to that of Aquacel® (percentage of debrided wounds respectively 52.5% vs 35.1%).

 

news-urgoclean

 

Overall, the investigating physicians have considered the Global Performance Score of UrgoClean®, which includes efficacy, safety and acceptability elements to be superior to that of Aquacel® (p=0.002).

 

UrgoClean®, expert in desloughing.

 

* Meaume S, Dissemond D, Addala A, Vanscheidt W, Stücker M, Goerge T, et al. Evaluation of two fibrous wound dressings for the management of leg ulcers: Results of a European randomised controlled trial (EARTH RCT). J Wound Care 2014;23 (3):105-116.

Last update : October 20, 2017